On Nov 18, 2021 Generate Biomedicines closed a Series B round and raised $370,000,000 from Abu Dhabi Investment Authority, Alaska Permanent Fund, Altitude Life Science […]
Post-IPO Equity – Cardiff Oncology
On Nov 18, 2021 Cardiff Oncology closed a Post-IPO Equity round and raised $15,000,000 from Pfizer Breakthrough Growth Initiative, featuring lead investors Pfizer Breakthrough Growth […]
Series A – Fountain Therapeutics
On Nov 18, 2021 Fountain Therapeutics closed a Series A round and raised $15,000,000 from Alexandria Venture Investments, Eli Lilly & Company Foundation, Khosla Ventures, […]
Corporate Round – Owkin
On Nov 18, 2021 Owkin closed a Corporate Round round and raised $180,000,000 from Sanofi, featuring lead investors Sanofi. About the company: Owkin is located […]
Series A – Filterlex Medical
On Nov 18, 2021 Filterlex Medical closed a Series A round and raised $6,000,000 from investors, featuring lead investors . About the company: Filterlex Medical […]
Post-IPO Equity – Cardiff Oncology
On Nov 18, 2021 Cardiff Oncology closed a Post-IPO Equity round and raised $15,000,000 from Pfizer Breakthrough Growth Initiative, featuring lead investors Pfizer Breakthrough Growth […]
Series A – Fountain Therapeutics
On Nov 18, 2021 Fountain Therapeutics closed a Series A round and raised $15,000,000 from Alexandria Venture Investments, Eli Lilly & Company Foundation, Khosla Ventures, […]
Series A – Filterlex Medical
On Nov 18, 2021 Filterlex Medical closed a Series A round and raised $6,000,000 from investors, featuring lead investors . About the company: Filterlex Medical […]
Seed Round – Asgard Therapeutics
On Nov 9, 2021 Asgard Therapeutics closed a Seed round and raised €6,000,000 from Boehringer Ingelheim Venture Fund, Industrifonden, Novo Holdings, featuring lead investors Boehringer […]
Series B – Variant Bio
On Nov 9, 2021 Variant Bio closed a Series B round and raised $105,000,000 from General Catalyst, SoftBank Vision Fund, Vulcan Capital, featuring lead investors […]
